Chile's CFR confirms Adcock Ingram bid
This article was originally published in Scrip
Executive Summary
The Chilean pharma group CFR Pharmaceuticals has agreed a cash and shares takeover deal for South Africa's Adcock Ingram valued at ZAR12.6bn ($1.3bn). The merger will create an emerging markets-focused multinational with sales of about $1.3bn, with Adcock Ingram contributing around 40% of revenues.